title: Polymorphisms in RAD51, XRCC2, and XRCC3 are not related to breast cancer risk.
authors.affiliation: Division of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016-3240, USA.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Brooks
authors.forename: Roy E
authors.initials: RE
authors.lastname: Shore
authors.forename: Anne
authors.initials: A
authors.lastname: Zeleniuch-Jacquotte
authors.forename: Diane
authors.initials: D
authors.lastname: Currie
authors.forename: Yelena
authors.initials: Y
authors.lastname: Afanasyeva
authors.forename: Karen L
authors.initials: KL
authors.lastname: Koenig
authors.forename: Alan A
authors.initials: AA
authors.lastname: Arslan
authors.forename: Paolo
authors.initials: P
authors.lastname: Toniolo
authors.forename: Isaac
authors.initials: I
authors.lastname: Wirgin
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics*; D015331:Cohort Studies; D004260:DNA Repair; D004268:DNA-Binding Proteins / Q000235:genetics*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009518:New York; D011110:Polymorphism, Genetic; D051135:Rad51 Recombinase / Q000235:genetics*; D011795:Surveys and Questionnaires; D016387:Women's Health
chemical_list: D004268:DNA-Binding Proteins; C110901:X-ray repair cross complementing protein 3; C113187:XRCC2 protein, human; C495153:RAD51 protein, human; D051135:Rad51 Recombinase